State Street Corp reports 7.20% increase in ownership of HTD / Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated

DE ˙ DB ˙ US2183521028

63,98 € ↑2,18 (3,53%)

2026-06-04
DEL PRIS

Security	DE:HTD / Corcept Therapeutics Incorporated
Institution	State Street Corp
Latest Disclosed Ownership	3,200,946 shares
Latest Disclosed Value	$ 129,030,133

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 3,200,946 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $110,400,628 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,986,056 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 7.20% during the quarter. The current value of the position is $204,796,525 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,200,946	214,890	7.20	129,030	24.17	0.0045
2026-02-13	2025-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	2,986,056	15,656	0.53	103,915	-57.91	0.0035
2025-11-14	2025-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	2,970,400	2,813	0.09	246,870	13.34	0.0086
2025-08-14	2025-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	2,967,587	-434,349	-12.77	217,821	-43.94	0.0082
2025-05-15	2025-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,401,936	-146,416	-4.13	388,569	117.32	0.0160
2025-02-14	2024-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,548,352	29,089	0.83	178,801	9.78	0.0071
2024-11-14	2024-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	3,519,263	19,893	0.57	162,871	43.25	0.0066
2024-08-14	2024-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	3,499,370	-76,156	-2.13	113,695	26.23	0.0050
2024-05-15	2024-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,575,526	188,061	5.55	90,068	-18.14	0.0040
2024-02-14	2023-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,387,465	244,414	7.78	110,025	28.48	0.0054
2023-11-14	2023-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	3,143,051	-23,243	-0.73	85,632	21.55	0.0047
2023-08-14	2023-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	3,166,294	-124,611	-3.79	70,450	-1.17	0.0037
2023-05-15	2023-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,290,905	92,211	2.88	71,281	9.72	0.0040
2023-05-15	2022-12-31	13F/A-99	CORCEPT THERAPEUTICS	COM	218352102	3,198,694	-264,904	-7.65	64,965	-26.85	0.0038
2023-05-15	2022-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,198,694	-264,904		64,965		0.0038
2022-11-15	2022-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	3,463,598	-35,848	-1.02	88,807	6.72	0.0056
2022-08-15	2022-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	3,499,446	89,888	2.64	83,217	8.38	0.0050
2022-05-16	2022-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,409,558	101,078	3.06	76,783	17.21	0.0038
2022-02-14	2021-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,308,480	35,737	1.09	65,508	1.71	0.0031
2021-11-15	2021-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	3,272,743	-9,129	-0.28	64,408	-10.79	0.0034
2021-08-16	2021-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	3,281,872	58,915	1.83	72,201	-5.83	0.0038
2021-07-09	2021-03-31	13F/A-1	CORCEPT THERAPEUTICS	COM	218352102	3,222,957	-7,475	-0.23	76,674	-9.27	0.0044
2021-05-17	2021-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,222,957	-7,475		76,674		0.0044
2021-02-16	2020-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,230,432	62,341	1.97	84,508	53.26	0.0052
2020-11-10	2020-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	3,168,091	-121,102	-3.68	55,141	-0.33	0.0038
2020-08-14	2020-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	3,289,193	114,590	3.61	55,324	46.57	0.0040
2020-06-19	2020-03-31	13F/A-1	CORCEPT THERAPEUTICS	COM	218352102	3,174,603	147,082	4.86	37,746	3.04	0.0033
2020-05-11	2020-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,174,603	147,082		37,746		3,314.8588
2020-02-06	2019-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,027,521	112,000	3.84	36,633	-11.11	0.0025
2019-11-14	2019-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	2,915,521	-86,666	-2.89	41,211	23.11	0.0031
2019-08-14	2019-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	3,002,187	-137,531	-4.38	33,474	-9.19	0.0025
2019-05-15	2019-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,139,718	197,367	6.71	36,860	-6.23	0.0029
2019-02-12	2018-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	2,942,351	-284,635	-8.82	39,310	-13.11	0.0036
2018-11-09	2018-09-30	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	3,226,986	318,429	10.95	45,242	-1.05	0.0035
2018-08-14	2018-06-30	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	2,908,557	-228,147	-7.27	45,720	-11.39	0.0038
2018-05-15	2018-03-31	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	3,136,704	263,711	9.18	51,596	-0.56	0.0044
2018-02-14	2017-12-31	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	2,872,993	929,689	47.84	51,889	38.34	0.0042
2017-11-14	2017-09-30	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	1,943,304	-84,709	-4.18	37,507	56.73	0.0032
2017-08-14	2017-06-30	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	2,028,013	420,139	26.13	23,931	35.79	0.0021
2017-05-15	2017-03-31	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	1,607,874	347,808	27.60	17,623	92.66	0.0016
2017-02-09	2016-12-31	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	1,260,066	55,533	4.61	9,147	16.83	0.0009
2017-01-13	2016-09-30	13F/A-1	CORCEPT THERAPEUTICS	Common equity shares	218352102	1,204,533	41,594	3.58	7,829	23.29	0.0008
2016-11-14	2016-09-30	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	1,204,533			7,829
2016-08-12	2016-06-30	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	1,162,939	260,699	28.89	6,350	50.40	0.0007
2016-05-20	2016-03-31	13F/A-1	CORCEPT THERAPEUTICS	Common equity shares	218352102	902,240	33,449	3.85	4,222	-2.31	0.0005
2016-05-12	2016-03-31	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	902,240			4,222
2016-02-16	2015-12-31	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	868,791	17,272	2.03	4,322	35.06	0.0005
2015-11-16	2015-09-30	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	851,519	12,622	1.50	3,200	-36.55	0.0004
2015-08-13	2015-06-30	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	838,897	-150,099	-15.18	5,043	-8.94	0.0005
2015-05-15	2015-03-31	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	988,996	26,707	2.78	5,538	91.69	0.0006
2015-02-11	2014-12-31	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	962,289	4,867	0.51	2,889	12.72	0.0003
2014-11-12	2014-09-30	13F/A-1	CORCEPT THERAPEUTICS	Common equity shares	218352102	957,422	48,989	5.39	2,563	0.75	0.0003
2014-11-10	2014-09-30	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	957,422			2,563
2014-08-12	2014-06-30	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	908,433	111,285	13.96	2,544	-26.83	0.0003
2014-05-15	2014-03-31	13F/A-1	CORCEPT THERAPEUTICS	Common equity shares	218352102	797,148	80,458	11.23	3,477	50.58	0.0004
2014-05-13	2014-03-31	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	797,148			3,477
2014-02-06	2013-12-31	13F/A-1	CORCEPT THERAPEUTICS	Common equity shares	218352102	716,690	21,070	3.03	2,309	109.53	0.0003
2014-02-06	2013-12-31	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	717,677			1,027
2013-11-12	2013-09-30	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	695,620	1,892	0.27	1,102	-8.17	0.0001
2013-08-08	2013-06-30	13F	CORCEPT THERAPEUTICS	Common equity shares	218352102	693,728	693,728		1,200		0.0002

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.